Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer
Clinical trial NCT04080804 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04080804
- Sponsor
- Dan Zandberg
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-20
- Primary completion
- 2027-10-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.